A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Arbutamine
Pyrazolam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Pyrazolam.
Arbutamine
Cinazepam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Cinazepam.
Arbutamine
Oxazepam acetate
The risk or severity of adverse effects can be increased when Flibanserin is combined with Oxazepam acetate.
Arbutamine
Perphenazine enanthate
The risk or severity of adverse effects can be increased when Flibanserin is combined with Perphenazine enanthate.
Arbutamine
Eslicarbazepine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Eslicarbazepine.
Arbutamine
Lithium carbonate
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lithium carbonate.
Arbutamine
Aripiprazole lauroxil
The risk or severity of adverse effects can be increased when Flibanserin is combined with Aripiprazole lauroxil.
Arbutamine
Cannabidivarin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Cannabidivarin.
Arbutamine
Nordazepam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Nordazepam.
Arbutamine
5-methoxy-N,N-dimethyltryptamine
The risk or severity of adverse effects can be increased when Flibanserin is combined with 5-methoxy-N,N-dimethyltryptamine.
Arbutamine
MRK-409
The risk or severity of adverse effects can be increased when Flibanserin is combined with MRK-409.
Arbutamine
Cyclopropane
The risk or severity of adverse effects can be increased when Flibanserin is combined with Cyclopropane.
Arbutamine
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when Flibanserin is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
Arbutamine
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when Flibanserin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
Arbutamine
Lormetazepam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lormetazepam.
Arbutamine
Clopenthixol
The risk or severity of adverse effects can be increased when Flibanserin is combined with Clopenthixol.
Arbutamine
Doxefazepam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Doxefazepam.
Arbutamine
Carbromal
The risk or severity of adverse effects can be increased when Flibanserin is combined with Carbromal.
Arbutamine
Reposal
The risk or severity of adverse effects can be increased when Flibanserin is combined with Reposal.
Arbutamine
Ethadione
The risk or severity of adverse effects can be increased when Flibanserin is combined with Ethadione.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3